FR2276825A2 - Pyrimidines condensees et leur preparation - Google Patents

Pyrimidines condensees et leur preparation

Info

Publication number
FR2276825A2
FR2276825A2 FR7517789A FR7517789A FR2276825A2 FR 2276825 A2 FR2276825 A2 FR 2276825A2 FR 7517789 A FR7517789 A FR 7517789A FR 7517789 A FR7517789 A FR 7517789A FR 2276825 A2 FR2276825 A2 FR 2276825A2
Authority
FR
France
Prior art keywords
alkyl
ones
alkoxy
hydroxy
pyrimido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7517789A
Other languages
English (en)
Other versions
FR2276825B2 (fr
Inventor
Thomas Henry Althuis
Leonard Joseph Czuba
Hans-Jurgen Ernst Hess
Saul Bernard Kadin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,945 external-priority patent/US3974161A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2276825A2 publication Critical patent/FR2276825A2/fr
Application granted granted Critical
Publication of FR2276825B2 publication Critical patent/FR2276825B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7517789A 1973-04-13 1975-06-06 Pyrimidines condensees et leur preparation Granted FR2276825A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35102573A 1973-04-13 1973-04-13
US05/485,945 US3974161A (en) 1974-02-20 1974-07-05 Fused pyrimidin-4(3H)-ones as antiallergy agents

Publications (2)

Publication Number Publication Date
FR2276825A2 true FR2276825A2 (fr) 1976-01-30
FR2276825B2 FR2276825B2 (fr) 1978-11-10

Family

ID=26996903

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7517789A Granted FR2276825A2 (fr) 1973-04-13 1975-06-06 Pyrimidines condensees et leur preparation

Country Status (2)

Country Link
FR (1) FR2276825A2 (fr)
NL (1) NL173270C (fr)

Also Published As

Publication number Publication date
FR2276825B2 (fr) 1978-11-10
NL173270B (nl) 1983-08-01
NL173270C (nl) 1984-01-02
NL7506665A (nl) 1976-01-07

Similar Documents

Publication Publication Date Title
AU699917C (en) Method of treating adenosine depletion
HUT75156A (en) New pharmaceutical composition containing combination of formoterol and budesonide
MY103963A (en) Isoquinoline derivatives, their preparation and their use
BRPI0516024A (pt) uso de azd 2171 ou de um sal farmaceuticamente aceitável do mesmo e de imatinib, composição farmacêutica, kit, e, método para a produção de um efeito antiangiogênico e/ou de redução da permeabilidade vascular em um animal de sangue quente
MY108541A (en) Purine derivatives and use thereof in therapy.
NZ216907A (en) Treatment of mycoplasmotic and bacterial infections in fowl
US6071919A (en) Zwitterionic compositions and methods as biological response modifiers
AU632487B2 (en) Improvements in or relating to organic compounds
FR2363329A1 (fr) Compositions renfermant du 4-carbamoyl-5-hydroxyimidazole, utiles comme agent pour le traitement de cancers, de rhumatismes et de nephrites
FR2276825A2 (fr) Pyrimidines condensees et leur preparation
KR880009975A (ko) 화합물
JPS6310728A (ja) ジサツカライド誘導体含有鎮痛剤
NO903211D0 (no) Salter av n5,n10-metylen-5-6-7-8-tetrahydrofolsyre samt fremgangsmaate for deres fremstilling.
US3743733A (en) Method of treating bronchial asthma
KR950005307A (ko) 약제학적 조성물
US3764699A (en) Methods for relieving bronchial spasm with prostaglandin-f{11 and derivatives
ES8202332A1 (es) Un metodo para la preparacion de sales de 4'-(9-acridinila- mino)-metanosulfon-m-anisidida
Feldstein In vitro decomposition of 1-adrenochrome
Wilson et al. Dimethyl ether of d-tubocurarine iodide as a curarizing agent in anaesthesia for thoracic surgery
US2145799A (en) Therapeutic preparation
SHEPARD et al. Further studies on use of streptomycin in treatment of whooping cough
JPS5610114A (en) Novel analgesic and anti-inflammatory agent
JPH0242056A (ja) テルルおよびセレン誘導体の複合体
FR2313923A1 (fr) Nouvelle association douee notamment d'une activite analgesique, myorelaxante, anxiolytique et anti-inflammatoire
Livingston et al. Actinomycin D